This undated combination of microscope images provided by Monash University in March 2021 shows different “iBlastoids” (embryo-like structures) stained to highlight different cell types. Scientists made the cell structures in a lab and say they will allow for more research into the earliest stages of human development without running afoul of restrictions on using real embryos. Photo: Monash University via AP  

For the first time, scientists have used human cells to make structures that mimic the earliest stages of development, which they say will pave the way for more research without running afoul of restrictions on using real embryos.

Two papers published on March 17 in the journal Nature detail how two teams of scientists independently made such structures.

Also read | Best from science journals: Million-year-old plant fossils beneath Greenland

They stressed that their work is only for research, not reproduction, but it likely will pose new ethical questions.

“Studying early human development is really difficult. It’s basically a black box,” said Jun Wu, a stem cell biologist at the University of Texas, Southwestern Medical Center. “We believe our model can open up this field,” he said, if “you can test your hypothesis without using human embryos.”

Dr. Wu’s team used embryonic stem cells and the second team used reprogrammed skin cells to produce balls of cells that resemble one of the earliest stages of human development.

These balls, called blastocysts, form a few days after an egg has been fertilised but before the cells attach to the uterus to become an embryo. To differentiate their models from blastocysts created through fertilisation, the researchers refer to the structures as “iBlastoids” and “human blastoids”.

“They shouldn’t be considered as equal to a blastocyst, although they are an excellent model for some aspects of biology,” said Jose Polo, an epigeneticist at Monash University in Australia who led the second research team.

Both groups stressed that the structures they made were not the same as naturally occurring embryos, and it’s unclear whether they could develop into viable embryos.

“The blastoids are less efficient in terms of generating structures mimicking later stage human embryos,” said Dr. Wu, whose team stopped growing the structure in a culture after four days.

Scientists previously generated similar structures of mouse cells in a lab, but this is the first time they have been made from human cells. The new models correspond to about three to 10 days after fertilisation, Dr. Wu said. In 2020, researchers unveiled structures that model cells 18 to 21 days after fertilisation.

Research involving human embryos and blastocysts is currently ineligible for federal funding in the U.S., and several States prohibit it outright.

Some scientists now use blastocysts donated from fertility clinics for research into the causes of infertility and congenital diseases. The new work should allow them to do such research at much larger scales, Dr. Polo said. “This capacity to work at scale will revolutionize our understanding of these early stages of human development,” said Dr. Polo.

The scientists stressed that their creations were not intended to be used for human reproduction.

“There is no implantation,” said Amander Clark, a stem cell biologist at the University of California, Los Angeles who co-authored the paper with Dr. Polo. “These structures are not transferred to a uterus or uterus-like structure,” she said. “There is no pregnancy.”

The distinction between blastocysts derived from fertilisation and the structures created in a lab may not be so clear-cut, said Shoukhrat Mitalipov, a human embryologist at Oregon Health and Science University who was not involved in the research.

“Both groups show how closely they resemble real embryos,” he said. “If they are really as good as embryos, should they be treated as embryos?”

“This brings new ethical issues,” he said. “Are they going to be covered as human embryos? Should restrictions apply?”

Scientists previously tried to turn the lab-generated mouse cell structures into embryos, but they were not successful.

The optimal scenario for research is to “get as close to a real embryo as possible so you can learn from it, but not a real embryo so you don’t get into debates about the moral status of embryos,” said Alta Charo, a professor emeritus of law and bioethics at University of Wisconsin who was not involved in the papers.

You have reached your limit for free articles this month.

Already have an account ? Sign in

Start your 14 days free trial. Sign Up

Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.

Enjoy reading as many articles as you wish without any limitations.

A select list of articles that match your interests and tastes.

Move smoothly between articles as our pages load instantly.

A one-stop-shop for seeing the latest updates, and managing your preferences.

We brief you on the latest and most important developments, three times a day.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

Dear reader,

We have been keeping you up-to-date with information on the developments in India and the world that have a bearing on our health and wellbeing, our lives and livelihoods, during these difficult times. To enable wide dissemination of news that is in public interest, we have increased the number of articles that can be read free, and extended free trial periods. However, we have a request for those who can afford to subscribe: please do. As we fight disinformation and misinformation, and keep apace with the happenings, we need to commit greater resources to news gathering operations. We promise to deliver quality journalism that stays away from vested interest and political propaganda.

Dear subscriber,

Thank you!

Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.

The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.

We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.

Suresh Nambath

Please enter a valid email address.

Subscribe to The Hindu now and get unlimited access.

Already have an account? Sign In

Start your 14 days free trial Sign Up

You can support quality journalism by turning off ad blocker or purchase a subscription for unlimited access to The Hindu.

Sign up for a 30 day free trial.